Apricus' French contract sales business succumbs to pricing pressures
This article was originally published in Scrip
Executive Summary
Apricus Biosciences will focus its resources going forward on its sexual dysfunction drugs and other products rather than put money into its recently acquired French sales and marketing subsidiaries due to pricing pressures in France and lost contracts.